Keeping Current

  • Author: Vários
  • Narrator: Vários
  • Publisher: Podcast
  • Duration: 299:30:30
  • More information

Informações:

Synopsis

Experts discuss relevant and actionable strategies for practice improvement as well as timely clinical topics.

Episodes

  • Targeting Angiopoietin-2: A New Approach in Retinal Diseases

    24/06/2022 Duration: 26min

    Can anything improve anti-vascular epithelial growth factor (anti-VEGF) control of exudation in retinal disease? Learn how targeting the angiopoietin pathway may help. Credit available for this activity expires: 6/23/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975535?src=mkm_podcast_addon_975535

  • How to Assess and Diagnose Food Allergies: Experts Discuss Best Practices and Recent Advancements

    23/06/2022 Duration: 34min

    With incidence of food-induced anaphylaxis on the increase, are you up to date on how best to diagnose and manage patients with food allergies? Credit available for this activity expires: 6/21/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975719?src=mkm_podcast_addon_975719

  • Advanced Age-Related Macular Degeneration: Assessment, Strategies, and New Therapies

    21/06/2022 Duration: 31min

    Do you know the best imaging modalities to diagnose advanced age-related macular degeneration (AMD) and track its progress? Learn how to assess patients and how to discuss with them what the future may hold. Credit available for this activity expires: 6/17/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975758?src=mkm_podcast_addon_975758

  • Novel Therapies for NSCLC With EGFR Exon 20 Insertions: Practical Pearls for the Clinic

    21/06/2022 Duration: 41min

    Are you aware that there are now targeted therapies available for patients harboring exon 20 insertions, the third most common type of EGFR mutation in non-small cell lung cancer (NSCLC)? Credit available for this activity expires: 6/20/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975726?src=mkm_podcast_addon_975726

  • Extending Horizons With Immune Checkpoint Inhibitors in Small Cell Lung Cancer: 2022 Perspectives

    17/06/2022 Duration: 40min

    Patients with extensive-stage small cell lung cancer (ES-SCLC) have a 10-month survival of 10 months following standard frontline chemotherapy. Join the experts in discussing immune checkpoint inhibitors (ICIs) in patients with SCLC. Credit available for this activity expires: 6/15/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975532?src=mkm_podcast_addon_975532

  • Clinical Perspectives on HER2-Targeted Antibody-Drug Conjugates: Treatment-Related Adverse Events

    15/06/2022 Duration: 37min

    Do you know how to safely manage treatment-related adverse events (TRAEs) associated with human epidermal growth factor receptor 2 (HER2)-targeted antibody-drug conjugates (ADCs)? Credit available for this activity expires: 6/14/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975383?src=mkm_podcast_addon_975383

  • International Heart Failure Guidelines and the Latest Data: Out of Complexities, Simplicities Emerge With SGLT2 Inhibitors

    14/06/2022 Duration: 33min

    What do the latest guidelines say about HF management? Drs Butler, Bozkurt, and McDonagh discuss. Credit available for this activity expires: 6/13/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975310?src=mkm_podcast_addon_975310

  • Epilepsy and Depression: Early Recognition or Double Trouble?

    13/06/2022 Duration: 34min

    Do you know how and when to screen for depression in people with epilepsy, and when to manage depression and when to refer? Credit available for this activity expires: 6/10/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975275?src=mkm_podcast_addon_975275

  • Addressing the Challenge of Endocrine-Resistant Breast Cancer

    02/06/2022 Duration: 37min

    Did you know that estrogen receptor-positive breast cancer often develops treatment resistance to endocrine therapy? Credit available for this activity expires: 5/31/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/974726?src=mkm_podcast_addon_974726

  • Addressing the Challenge of HER2 Heterogeneity in Breast Cancer

    01/06/2022 Duration: 34min

    Did you know that there is a paradigm shift in the definition of human epidermal growth factor receptor 2 (HER2) status in breast cancer? Credit available for this activity expires: 5/31/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/974715?src=mkm_podcast_addon_974715

  • Management Strategies to Optimize Outcomes in CKD-aP: A Case-Based Discussion

    27/05/2022 Duration: 34min

    How well are you managing pruritus in your patients on dialysis? Join this activity to learn about latest developments in chronic kidney disease-associated pruritus (CKD-aP). Credit available for this activity expires: 5/26/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/973462?src=mkm_podcast_addon_973462

  • RSV: Omnipresent and Inescapable

    27/05/2022 Duration: 18min

    Did you know that 3.5 million children are hospitalized each year with a respiratory syncytial virus (RSV) infection, but the true burden is unknown due to a lack of diagnosis? Credit available for this activity expires: 5/26/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/974410?src=mkm_podcast_addon_974410

  • The Molecular Tumor Board: Best Practices for Managing Primary and Acquired EGFR TKI Resistance

    24/05/2022 Duration: 45min

    Do you know that primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) occurs in approximately 20% to 30% of patients with EGFR-mutated non-small cell lung cancer (NSCLC), and acquired resistance is inevitable? Credit available for this activity expires: 5/23/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/974097?src=mkm_podcast_addon_974097

  • The Implications of the Latest Data on SGLT2 Inhibitors in Heart Failure: A Unified Approach to Treatment?

    17/05/2022 Duration: 29min

    Drs Zieroth and Anker discuss heart failure (HF) outcome trials with sodium-glucose cotransporter-2 (SGLT2) inhibitors. Credit available for this activity expires: 5/17/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/972924?src=mkm_podcast_addon_972924

  • Managing Psoriatic Disease With Biologic Therapies

    12/05/2022 Duration: 35min

    Did you know that over the past years, the percentage of patients who report entheseal involvement in clinical studies has almost doubled from approximately 30% to 60%? Credit available for this activity expires: 5/10/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/973518?src=mkm_podcast_addon_973518

  • Leber Hereditary Optic Neuropathy Gene Therapy – Who Should Be Treated and How?

    11/05/2022 Duration: 31min

    Do you know how you should treat patients with Leber hereditary optic neuropathy (LHON)? Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/973546?src=mkm_podcast_addon_973546

  • Evolving Perspectives on How to Achieve Successful Outcomes in Crohn Disease

    10/05/2022 Duration: 30min

    Join expert faculty as they discuss the T2T approach and guideline recommendations for CD. Credit available for this activity expires: 5/9/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/972809?src=mkm_podcast_addon_972809

  • Immunopathogenesis of Hidradenitis Suppurativa

    10/05/2022 Duration: 26min

    Join Dr Krueger for an overview of our current understanding of the mechanisms underlying HS pathogenesis & potential treatment approaches. Credit available for this activity expires: 5/9/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/963768?src=mkm_podcast_addon_963768

  • Treat Across the Heart Failure Spectrum or Dichotomize by Ejection Fraction Category? The Experts Debate

    04/05/2022 Duration: 35min

    Drs Coats, Lam, and Lund discuss the management of patients with HF across the EF spectrum. Credit available for this activity expires: 5/3/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/972842?src=mkm_podcast_addon_972842

  • The Patient With Chronic Ocular Surface Pain: Taking the Next Step

    03/05/2022 Duration: 37min

    Do you know how to recognize and manage chronic ocular surface pain? Listen in as our experts discuss how to take the next step in treating this disease. Credit available for this activity expires: 5/2/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/972837?src=mkm_podcast_addon_972837

page 14 from 28